ipa3 (Santa Cruz Biotechnology)
Structured Review
Ipa3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ipa3/IPA+3/pmc03578113-108-1-10
Average 90 stars, based on 11 article reviews
Images
Related Articles
Indirect Immunoperoxidase Assay:Article Title: Rapid Estrogen and Progesterone Signaling to Dendritic Spine Formation via Cortactin/Wave1-Arp2/3 Complex. Article Snippet: .. Progesterone, 17β-estradiol and Forskolin (1 μM) were from Sigma-Aldrich; PP2 (Src inhibitor, 10μM) and Roscovitine3 (Cdk5 inhibitor, 50μM) were from Calbiochem; FAK inhibitor (FAKi, (1 μM), Article Title: Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer. Article Snippet: Purpose Heregulin (HRG) signaling has been implicated in the development of an aggressive phenotype in breast cancer (BC) cells, and HER2 overexpression has been associated with a worse prognosis in BC patients.. Nevertheless, the molecular mechanisms through which HRG affects the efficiency of anti-HER2 therapies such as trastuzumab (Tz) and trastuzumabemtansine (T-DM1) are currently unknown.. Methods In the present study, we evaluate the molecular action of HRG toward fundamental scaffold proteins and several kinases in the signal transduction pathways triggered via HER2/HER3, which integrate precise and sequential steps to promote changes in cell morphology to impulse BC cell migration. Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Recombinant:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Clinical Proteomics:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # MTT Assay:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Sterility:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Polymerase Chain Reaction:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Cloning:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Mutagenesis:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # shRNA:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Plasmid Preparation:Article Title: PAK4 Kinase Activity Plays a Crucial Role in the Podosome Ring of Myeloid Cells Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # sc-204016 Akt inhibitor Fibronectin from bovine plasma 0.1% solution Sigma Cat. # F1141 Fibronectin HiLyte 488 Cytoskeleton, Inc. Cat. # FNR02-A Human M-CSF Miltenyi Biotec Cat. # 103-093-963 MTT reagent Sigma Cat. # M5655 DMSO, sterile filtered Sigma Cat. # D2438 MCP-1 (CCL2) R&D Systems Cat. # 279-MC-010 Critical Commercial Assays Zero Blunt PCR Cloning Kit Invitrogen Cat. # K2700-20 QuikChange XL Site-Directed Mutagenesis Kit Stratagene Cat. # 200516 15ml Lymphoprep Axis-Shield Cat. # 1114544 CD14 Microbeads, human Miltenyi Biotec Cat. # 103-050-201 Experimental Models: Cell Lines THP-1 cells ATCC TIB-202 HEK293T cells ATCC CRL-3216 Oligonucleotides Cloning primer: PAK4 shRNA 2 FWD: CCGGGGTGAACATGTATG AGTGCTCGAGCACTCATACATGTTCACCTTTTTG This paper N/A Cloning primer: PAK4 shRNA 2 REV: AATTCAAAAAGGTGAACATG TATGAGTGCTCGAGCACTCATACATGTTCACC This paper N/A Cloning primer: PAK4 shRNA 3 FWD: CCGGCTTCGGACATTCATG ATCGCTCGAGCGATCATGAATGTCCGAAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 3 REV: AATTCAAAAACTTCGGACAT TCATGATCGCTCGAGCGATCATGAATGTCCGAAG This paper N/A Cloning primer: PAK4 shRNA 4 FWD: CCGGCTGCTGGACGAGTT TGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAGTTTTTG This paper N/A Cloning primer: PAK4 shRNA 4 REV: AATTCAAAAACTGCTGGAC GAGTTTGAGAACCTCGAGGTTCTCAAACTCGTCCAGCAG This paper N/A SDM primer: PAK4 shRNA 4 rescue FWD: GCCCTCACGCTGCTC CTCGATGAGTTCGAGAACATGTC This paper N/A SDM primer: PAK4 shRNA 4 rescue REV: GACATGTTCTCGAACT CATCGAGGAGCAGCGTGAGGGC This paper N/A SDM primer: PAK4r(K350,351M) FWD: CTGGTGGCCGTCATGAT GATGGACCTGCGC Wells laboratory N/A SDM primer: PAK4r(K350,351M) REV: GCGCAGGTCCATCATCAT GACGGCCACCAG Wells laboratory N/A See Table S1 for more details of oligonucleotides used in this study Recombinant DNA pHR’SINcPPT-SFFV (pLNT-SffV) Jones laboratory; Vijayakumar et al., 2015 N/A pLKO.1 Addgene; Moffat et al., 2006 Addgene Plasmid 10878 pCMVDR8.91 Jones laboratory N/A pMD.G Jones laboratory N/A pDEST27-PAK4 Wells laboratory N/A pLNT/SffV-EGFP-PAK4 This paper N/A pLNT/SffV-EGFP-PAK4(rescue) This paper N/A (Continued on next page) Cell Reports 29, 3385–3393.e1–e6, December 10, 2019 e2 .. REAGENT or RESOURCE SOURCE IDENTIFIER Chemicals, Peptides, and Recombinant Proteins Recombinant Human TGF-b1 R&D Systems Cat. # 240-B-002 PAK4i (CRTDL4) Cancer Research Technology N/A IPA-3 Santa Cruz Biotechnology Cat. # Incubation:Article Title: Synthesis, biological evaluation and toxicity of novel tetrandrine analogues Article Snippet: On the following day, cells were transfected with either pcDNA3-CYP3A4-EGFP or pcDNA3EGFP using the LipofectamineTM 3000 (Invitrogen, Waltham, USA) transfection reagent according to the manufacturer’s instructions. .. On the subsequent day, cells were incubated with Article Title: Synthesis, biological evaluation and toxicity of novel tetrandrine analogues Article Snippet: On the following day, cells were transfected with either pcDNA3-CYP3A4-EGFP or pcDNA3-EGFP using the LipofectamineTM 3000 (Invitrogen, Waltham, USA) transfection reagent according to the manufacturer’s instructions. .. On the subsequent day, cells were incubated with |

